TY - JOUR
T1 - Pathology of transitional cell carcinoma of the bladder and its clinical implications
AU - Lapham, Rosanna L.
AU - Ro, Jae Y.
AU - Staerkel, Gregg A.
AU - Ayala, Alberto G.
PY - 1997/9
Y1 - 1997/9
N2 - Transitional cell carcinomas are divided into superficial and muscle- invasive tumors. Most of them are superficial tumors; and approximately 15- 20% are muscle-invasive carcinomas. Pathologists play a significant role in diagnosing bladder tumors and in reporting features important for determining prognosis. We will review the cytologic and histopathologic features that help determine prognosis, including depth of invasion, tumor grade, multicentricity, tumor size, and the presence of vascular/lymphatic invasion, blood group antigen expression, proliferative indices, and molecular markers. Brief mention will be made of specimen handling, interpretation, reporting, and histologic variants of transitional cell carcinoma.
AB - Transitional cell carcinomas are divided into superficial and muscle- invasive tumors. Most of them are superficial tumors; and approximately 15- 20% are muscle-invasive carcinomas. Pathologists play a significant role in diagnosing bladder tumors and in reporting features important for determining prognosis. We will review the cytologic and histopathologic features that help determine prognosis, including depth of invasion, tumor grade, multicentricity, tumor size, and the presence of vascular/lymphatic invasion, blood group antigen expression, proliferative indices, and molecular markers. Brief mention will be made of specimen handling, interpretation, reporting, and histologic variants of transitional cell carcinoma.
KW - Antigens
KW - Biological tumor markers
KW - Biopsy
KW - Bladder neoplasms
KW - Blood groups
KW - Cystectomy
KW - Differential diagnosis
KW - Neoplasm invasiveness
KW - Neoplasm staging
KW - Prognosis
KW - Survival rate
KW - Transitional cell carcinoma
UR - http://www.scopus.com/inward/record.url?scp=0030841339&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0030841339&partnerID=8YFLogxK
U2 - 10.1002/(SICI)1098-2388(199709/10)13:5<307::AID-SSU4>3.0.CO;2-H
DO - 10.1002/(SICI)1098-2388(199709/10)13:5<307::AID-SSU4>3.0.CO;2-H
M3 - Review article
C2 - 9259086
AN - SCOPUS:0030841339
SN - 8756-0437
VL - 13
SP - 307
EP - 318
JO - Seminars in Surgical Oncology
JF - Seminars in Surgical Oncology
IS - 5
ER -